| For: | Minaga K, Watanabe T, Kamata K, Asano N, Kudo M. Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review. World J Gastroenterol 2018; 24(16): 1725-1733 [PMID: 29713127 DOI: 10.3748/wjg.v24.i16.1725] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i16/1725.htm |
| Number | Citing Articles |
| 1 |
Roghayeh Mohammadzadeh, Shaho Menbari, Abbas Pishdadian, Hadi Farsiani. Helicobacter pylorivirulence factors: subversion of host immune system and development of various clinical outcomes. Expert Reviews in Molecular Medicine 2023; 25 doi: 10.1017/erm.2023.17
|
| 2 |
Indranil Chattopadhyay, Rohit Gundamaraju, Ashwin Rajeev. Diversification and deleterious role of microbiome in gastric cancer. Cancer Reports 2023; 6(11) doi: 10.1002/cnr2.1878
|
| 3 |
Ravi Bharadwaj, Madison V. Anonick, Swati Jaiswal, Siavash Mashayekh, Ashley Brown, Kimberly A. Wodzanowski, Kendi Okuda, Neal Silverman, Catherine L. Grimes. Synthesis and validation of click-modified NOD1/2 agonists. Innate Immunity 2023; 29(8) doi: 10.1177/17534259231207198
|
| 4 |
Qingbin Niu, Jun Zhu, Xingquan Yu, Tao Feng, Hong Ji, Yuming Li, Weiwei Zhang, Baoguang Hu. Immune Response in H. pylori-Associated Gastritis and Gastric Cancer. Gastroenterology Research and Practice 2020; 2020 doi: 10.1155/2020/9342563
|
| 5 |
Siru Nie, Yuan Yuan, Margarete D. Bagatini. The Role of Gastric Mucosal Immunity in Gastric Diseases. Journal of Immunology Research 2020; 2020(1) doi: 10.1155/2020/7927054
|
| 6 |
Tran Thi Dieu Thuy, Pei-Yun Kuo, Sha-Ma Lin, Cheng-Yen Kao. Anti-Helicobacter pylori activity of potential probiotic Lactiplantibacillus pentosus SLC13. BMC Microbiology 2022; 22(1) doi: 10.1186/s12866-022-02701-z
|
| 7 |
Yangyun Wang, Youyang Shi, Jingjing Duan, Haijia Tang, Sheng Liu, Jianfeng Yang. The Role of the Microbiome in Cancer Development. Cancer Biome and Targeted Therapy 2026; doi: 10.66505/cbtt.v1i1.19
|
| 8 |
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh. The important role played by chemokines influence the clinical outcome of Helicobacter pylori infection. Life Sciences 2019; 231 doi: 10.1016/j.lfs.2019.116688
|
| 9 |
Ruby Dawson, Brendan J. Jenkins. Research and Clinical Applications of Targeting Gastric Neoplasms. 2021; doi: 10.1016/B978-0-323-85563-1.00007-1
|
| 10 |
Jaehoon Cho, Akriti Prashar, Nicola L. Jones, Steven F. Moss. Helicobacter pylori Infection. Gastroenterology Clinics of North America 2021; 50(2) doi: 10.1016/j.gtc.2021.02.001
|
| 11 |
Hajar El Filaly, Christophe Desterke, Ahmed Outlioua, Wafaa Badre, Moncef Rabhi, Mehdi Karkouri, Myriam Riyad, Abdelouahed Khalil, Damien Arnoult, Khadija Akarid. CXCL-8 as a signature of severe Helicobacter pylori infection and a stimulator of stomach region-dependent immune response. Clinical Immunology 2023; 252 doi: 10.1016/j.clim.2023.109648
|
| 12 |
Abrar J. Hassan, Rana Saadi Aboud. Anti-Helicobacter pylori Antibodies Detected in the Sera of Iraqi Patients with Multiple Sclerosis. Medical Journal of Babylon 2025; 22(4) doi: 10.4103/MJBL.MJBL_1044_23
|
| 13 |
Ahmad Karkhah, Soheil Ebrahimpour, Maryam Rostamtabar, Veerendra Koppolu, Sorena Darvish, Veneela Krishna Rekha Vasigala, Majid Validi, Hamid Reza Nouri. Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases. Microbiological Research 2019; 218 doi: 10.1016/j.micres.2018.09.011
|
| 14 |
Sergey Yu. Chekhomov, Yuri Yu. Eliseev. Hygienic requirements regarding to population safety for cancirogenic factors of biological nature (a review). Saratov Journal of Medical Scientific Research 2024; 20(3) doi: 10.15275/ssmj2003301
|
| 15 |
Victoria Fernández-García, Silvia González-Ramos, Paloma Martín-Sanz, Francisco García-del Portillo, José Moisés Laparra, Lisardo Boscá. NOD1 in the interplay between microbiota and gastrointestinal immune adaptations. Pharmacological Research 2021; 171 doi: 10.1016/j.phrs.2021.105775
|
| 16 |
Hongyang Zhao, Beiwu Lan, Zenghui Zhao, Peining Zhu, Chong Wang, Yufei Gao. High expression of nucleotide-binding oligomerization domain protein 1 correlates with poor prognosis and immune cell infiltration in Glioblastoma Multiforme patients. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-01786-y
|
| 17 |
Sanjib Das, Prolay Halder, Soumalya Banerjee, Samima Sultana, Arindam Mukherjee, Pritam Nandy, Ashis Debnath, Asish Kumar Mukhopadhyay, Shanta Dutta, Hemanta Koley. A prophylactic study of curcumin nanoparticle-induced bacterial ghosts against Helicobacter pylori in a C57BL/6 mouse model. Microbial Pathogenesis 2025; 209 doi: 10.1016/j.micpath.2025.108084
|
| 18 |
Weihong Kuang, Jialin Xu, Fenting Xu, Weizhen Huang, Muhammad Majid, Hui Shi, Xia Yuan, Yongdui Ruan, Xianjing Hu. Current study of pathogenetic mechanisms and therapeutics of chronic atrophic gastritis: a comprehensive review. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1513426
|
| 19 |
Jian Chen, Li Zhou, Ling Li, Yue Wang. Helicobacter pylori promote M1 macrophage polarization via JAK3-mediated activation of the SOCS3/IL2RA axis to suppress host immunity. Archives of Microbiology 2026; 208(11) doi: 10.1007/s00203-026-05104-0
|
| 20 |
Sevgi Kalkanli Tas, Duygu Kirkik, Derya Altunkanat, Aylin Seher Uzunoglu, Merve Saide Uzunoglu, Bengu Akcam Celik, Elifnaz Ilgar. Immune Response and Therapeutic Vaccination against Helicobacter pylori. Brazilian Archives of Biology and Technology 2023; 66 doi: 10.1590/1678-4324-2023230123
|
| 21 |
Monika Maria Biernat, Tomasz Wróbel. Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment. International Journal of Molecular Sciences 2021; 22(14) doi: 10.3390/ijms22147372
|
| 22 |
Surinder M. Soond, Andrey A. Zamyatnin. Helicobacter pylori and gastric cancer: a lysosomal protease perspective. Gastric Cancer 2022; 25(2) doi: 10.1007/s10120-021-01272-8
|
| 23 |
Kritika Malik, Prashant Kodgire.
Insights into the molecular mechanisms of
H. pylori
-associated B-cell lymphoma
. Critical Reviews in Microbiology 2024; 50(5) doi: 10.1080/1040841X.2024.2305439
|
| 24 |
Philippe Lehours, Richard L. Ferrero. Review: Helicobacter: Inflammation, immunology, and vaccines. Helicobacter 2019; 24(S1) doi: 10.1111/hel.12644
|
| 25 |
A.A. Svistunov, M.A. Osadchuk, E.D. Mironova, E.S. Ogibenina. Helicobacter pylori infection as a risk factor for gastrointestinal cancer. Profilakticheskaya meditsina 2021; 24(11) doi: 10.17116/profmed202124111105
|
| 26 |
Dharmendra Kashyap, Samiksha Rele, Pranit Hemant Bagde, Vaishali Saini, Debi Chatterjee, Ajay Kumar Jain, Rajan Kumar Pandey, Hem Chandra Jha. Comprehensive insight into altered host cell-signaling cascades upon Helicobacter pylori and Epstein–Barr virus infections in cancer. Archives of Microbiology 2023; 205(7) doi: 10.1007/s00203-023-03598-6
|